Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ferric Citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 161Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akebia Therapeutics Reports Q2 2024 Results And Business Highlights
    Akebia Therapeutics Reports Q2 2024 Results And Business Highlights

    08 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-second-quarter-2024-financial-results-and-recent-business-highlights-302217366.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    Akebia Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia
    Akebia Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia

    29 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-positive-top-line-results-of-phase-4-impact-study-of-auryxia-ferric-citrate-for-in-center-and-home-dialysis-patients-301866373.html

    PR NEWSWIRE
    29 Jun 2023
    Share Share
    Enforcement Report - Week of February 24, 2021
    Enforcement Report - Week of February 24, 2021

    24 Feb 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf

    FDA
    24 Feb 2021
    Share Share
    Enforcement Report - Week of December 30, 2020
    Enforcement Report - Week of December 30, 2020

    30 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf

    FDA
    30 Dec 2020
    Share Share
    Enforcement Report - Week of July 22, 2020
    Enforcement Report - Week of July 22, 2020

    22 Jul 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-22-2020-1595395565.pdf

    FDA
    22 Jul 2020
    Share Share
    Akebia Announces Data on Different Dosing Regimens of Ferric Citrate
    Akebia Announces Data on Different Dosing Regimens of Ferric Citrate

    10 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-data-on-different-dosing-regimens-of-ferric-citrate-for-iron-deficiency-anemia-presented-at-57th-era-edta-virtual-congress-301073213.html

    PRNEWSWIRE
    10 Jun 2020
    Share Share